Biorce: Difference between revisions

From Research Wiki
Added valuation: ~€200M implied ($52.5M Series A, 2025)
Added founded year: 2019
 
Line 1: Line 1:
{{Company
{{Company
|name=Biorce
|name=Biorce
|founded=2019
|location=Barcelona, Spain
|location=Barcelona, Spain
|category=AI Clinical Trials
|category=AI Clinical Trials

Latest revision as of 08:29, 14 April 2026

Template:Company

What They Do[edit]

AI-driven clinical trials platform accelerating drug development. Uses machine learning to optimize trial design, patient recruitment, and protocol optimization.

Funding[edit]

Valuation: ~€200M implied ($52.5M Series A, 2025) €43.8M Series A (2025)

See Also[edit]